What is the target price for Cronos Group?
Their forecasts range from C$4.08 to C$14.00. On average, they expect Cronos Group's stock price to reach C$8.65 in the next year. This suggests a possible upside of 83.0% from the stock's current price. View analysts' price targets for Cronos Group or view top-rated stocks among Wall Street analysts. Who are Cronos Group's key executives?
What is Cronos Group's stock symbol?
What is Cronos Group's stock symbol? Cronos Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CRON." How do I buy shares of Cronos Group? Shares of CRON and other Canadian stocks can be purchased through an online brokerage account.
How do I buy shares of cron?
Shares of CRON and other Canadian stocks can be purchased through an online brokerage account.
What is the long term earning potential of cron stock?
NASDAQ:CRON The CRON stock price can go up from 6.885 USD to 12.089 USD in one year. The long-term earning potential is +75.59% in one year. In five years (2024) The CRON ("CRON" ) future stock price will be 21.804 USD.
Is CRON a good stock to buy now?
The financial health and growth prospects of CRON, demonstrate its potential to underperform the market. It currently has a Growth Score of F. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.
What does Cronos Group sell?
Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.
How many shares of Cronos are there?
Share StatisticsAvg Vol (3 month) 31.94MShares Outstanding 5375.58MImplied Shares Outstanding 6N/AFloat 8198.76M% Held by Insiders 147.22%7 more rows
What does Cronos Group do?
Cronos Group is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos Group is building an iconic brand portfolio.
Is Cronos a good long term investment?
Is Cronos a good investment? It might be. Cronos (CRO) certainly performed well over the course of 2021, increasing 1,400% from January to November 2021, and it is still trading above its yearly averages from 2018, 2019 and 2020.
Will Cronos stock go back up?
The 10 analysts offering 12-month price forecasts for Cronos Group Inc have a median target of 3.49, with a high estimate of 8.45 and a low estimate of 2.96. The median estimate represents a +17.85% increase from the last price of 2.96.
Why did Cronos stock go up today?
Shares of global cannabis company Cronos Group (CRON 0.64%) rocketed higher on Tuesday after the company reported its earnings for the first three months of 2022. The company missed Wall Street's earnings per share (EPS) estimates, but investors were happy with its solid growth numbers.
How much is Cronos?
The current price is $1.145192 per CRONO.
How much cash does Cron have?
When Cronos Group last reported its balance sheet in March 2022, it had zero debt and cash worth US$981m.
How big is Cronos?
1600 feet tallHe was also the only Titan brave enough to stand up to his father Ouranos, dismember him, and become the new ruler of the world. Standing at 1600 feet tall, Cronos is easily the largest titan in the God of War series.
What happened to Cronos?
Zeus grew up, forced Cronus to disgorge his brothers and sisters, waged war on Cronus, and was victorious. After his defeat by Zeus, Cronus became, according to different versions of his story, either a prisoner in Tartarus or king in Elysium.
Does Cronos Group pay dividends?
Does Cronos Group pay a dividend? Does it plan to? The Company does not pay a dividend.
Should I buy or sell Cronos Group stock right now?
8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 2 sel...
What is Cronos Group's stock price forecast for 2022?
8 Wall Street analysts have issued twelve-month target prices for Cronos Group's stock. Their forecasts range from $3.00 to $6.00. On average, they...
How has Cronos Group's stock price performed in 2022?
Cronos Group's stock was trading at $3.92 on January 1st, 2022. Since then, CRON shares have decreased by 30.4% and is now trading at $2.73. View...
When is Cronos Group's next earnings date?
Cronos Group is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022. View our earnings forecast for Cronos Gr...
How were Cronos Group's earnings last quarter?
Cronos Group Inc. (NASDAQ:CRON) posted its earnings results on Tuesday, May, 10th. The company reported ($0.09) EPS for the quarter, missing analys...
Who are Cronos Group's key executives?
Cronos Group's management team includes the following people: Mr. Michael Ryan Gorenstein J.D. , Pres, CEO & Chairman (Age 35, Pay $389.15k) ( L...
Who are some of Cronos Group's key competitors?
Some companies that are related to Cronos Group include Tilray (TLRY) , Canopy Growth (CGC) , USANA Health Sciences (USNA) , Cresco Labs (CRLBF...
What other stocks do shareholders of Cronos Group own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include (CGC) , Aurora Cannab...
What is Cronos Group's stock symbol?
Cronos Group trades on the NASDAQ under the ticker symbol "CRON."
How much does Cronos Group make?
Is Cronos Group a hold?
Cronos Group has a market capitalization of $2.66 billion and generates $46.72 million in revenue each year. The company earns $-73,140,000.00 in net income (profit) each year or ($0.38) on an earnings per share basis.
What time do you trade in the pre market?
Wall Street analysts have given Cronos Group a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cronos Group wasn't one of them.
Does market cap include convertible securities?
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. Stock prices may also move more quickly in this environment.
Where does Cronos grow cannabis?
It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable).
Where is Cronos located?
Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the c.
Ideas
111 PETER STREET SUITE 300, TORONTO, Ontario, M5V2G9, Canada +1 416 504-0004. Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach.
Profile
Really like this cron count, it helps me check off another in the list of bull on the cannabis side. I think we have a good year in MJ coming.
About Cronos Group
Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.
Headlines
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States.
Cronos Group (TSE:CRON) Frequently Asked Questions
Has CoDiagnostics, Inc. (CODX) Outpaced Other Medical Stocks This Year?
